Arbutus Biopharma (ABUS) Return on Equity [ROE] (2011 - 2026)
Arbutus Biopharma (ABUS) recorded Return on Equity [ROE] of 58.74% in Q2 2026, up 125.66 percentage points from -66.92% a year earlier but down 36.31 percentage points from the prior quarter.
Powered by 
Analysis
Arbutus Biopharma (ABUS) Return on Equity [ROE] (2011 - 2026) Analysis & Trends
For FY2025, Arbutus Biopharma reported Return on Equity [ROE] of -39.31%, up 29.45 percentage points from FY2024.
- Annual Return on Equity [ROE] has a five-year change of +33.66 percentage points (FY2020 to FY2025).
- Across earlier years, Return on Equity [ROE] came in at -68.76% in FY2024 (-8.77 pp), -59.99% in FY2023 (-14.64 pp), -45.35% in FY2022 (+10.83 pp) and -56.19% in FY2021 (+16.79 pp).
- Quarterly Return on Equity [ROE] has ranged from -86.72% in Q1 2025 to 95.05% in Q1 2026 over the past five years.
- On a year-over-year basis, Return on Equity [ROE] has increased for four consecutive quarters, with an average year-over-year change of +39.15 percentage points over the last eight quarters.
- Peak year-over-year performance for Return on Equity [ROE] in the last five years was a gain of 181.77 percentage points in Q1 2026, against a drop of 19.31 percentage points in Q1 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at 95.05% (Q1 2026), -44.41% (Q4 2025) and -52.70% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.66% |
| 10 | Arbutus Biopharma | 758.95 Mn | 142.14 Mn | - | 88.64% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 88.64% |
| Jun 30, 2026 | 59.01% |
| Mar 31, 2026 | 95.50% |
| Dec 31, 2025 | -43.47% |
| Sep 30, 2025 | -52.77% |
| Jun 30, 2025 | -66.77% |
| Mar 31, 2025 | -86.52% |
| Dec 31, 2024 | -68.18% |
| Sep 30, 2024 | -66.19% |
| Jun 30, 2024 | -64.05% |
| Mar 31, 2024 | -66.28% |
| Dec 31, 2023 | -62.82% |
| Sep 30, 2023 | -57.75% |
| Jun 30, 2023 | -51.90% |
| Mar 31, 2023 | -50.05% |
| Dec 31, 2022 | -50.72% |
| Sep 30, 2022 | -47.99% |
| Jun 30, 2022 | -45.38% |
| Mar 31, 2022 | -45.88% |
| Dec 31, 2021 | -51.04% |
API Access
Arbutus Biopharma Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ABUS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "ABUS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ABUS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();